RANI — RANI THERAPEUTICS HLDGS INC

Ownership history in Well Done, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Well Done, LLC reported a position in RANI THERAPEUTICS HLDGS INC (RANI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q4)
Avg. % of fund
0.01%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 52,014 — 0% 0.01% $70K $1.35
2025 Q3 UNCHANGED 52,014 — 0% 0.00% $26K $0.50
2025 Q2 INITIATED 52,014 — — 0.01% $27K $0.51
% of Fund (quarterly)    RANI price (monthly, adj. close)

Other funds also holding RANI

As of 2025 Q4 — sorted by position size

Samsara BioCapital, LLC 3Y 7Y 1.18% AWM Investment Company, Inc. 3Y 7Y 0.85% Nan Fung Group Holdings Ltd 3Y 0.6% Longaeva Partners L.P. 0.24% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.12% Siren, L.L.C. 0.08% 683 Capital Management, LLC 3Y 7Y 0.03% UNITED SERVICES AUTOMOBILE ASSOCIATION 3Y 7Y 0.03% ACT Advisors, LLC. 3Y 0.01% ISLAY CAPITAL MANAGEMENT, LLC 3Y 0.01%
← Back to Well Done, LLC Holdings